Companies / Epizyme, Inc.
Epizyme, Inc.
EPZMCIK 1571498
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jan 31, 2022 | Legorreta Pablo G. Director | Buy Open-market buy | Common Stock | $34.00M | +22.7M +247.27% | 31,833,334 | high |
| Aug 9, 2022 | Bogle Grant C. Executive | Exercise Option exercise | Common Stock, par value $0.0001 | $1.11M | +800K +437.02% | 983,060 | low |
| Aug 9, 2022 | Bogle Grant C. Executive | Other Withheld for taxes | Common Stock, par value $0.0001 | $1.04M | -746K -75.92% | 236,753 | low |
| Aug 9, 2022 | Bogle Grant C. Executive | Exercise Option exercise | Common Stock, par value $0.0001 | $588.7K | +418K +176.34% | 654,253 | low |
| Aug 9, 2022 | Bogle Grant C. Executive | Other Withheld for taxes | Common Stock, par value $0.0001 | $557.1K | -395K -60.39% | 259,170 | low |
| Aug 9, 2022 | Agarwal Shefali Executive | Exercise Option exercise | Common Stock, par value $0.0001 | $556.0K | +400K +154.61% | 658,716 | low |
| Aug 9, 2022 | Kutok Jeffery Executive | Exercise Option exercise | Common Stock, par value $0.0001 | $528.2K | +380K +401.85% | 474,563 | low |
| Aug 9, 2022 | Agarwal Shefali Executive | Other Withheld for taxes | Common Stock, par value $0.0001 | $518.7K | -373K -56.65% | 285,562 | low |